annual working capital:
$98.11M-$1.52B(-93.95%)Summary
- As of today (August 16, 2025), TAK annual working capital is $98.11 million, with the most recent change of -$1.52 billion (-93.95%) on March 1, 2025.
- During the last 3 years, TAK annual working capital has fallen by -$3.59 billion (-97.34%).
- TAK annual working capital is now -99.46% below its all-time high of $18.24 billion, reached on March 31, 2008.
Performance
TAK Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$2.38B+$2.28B(+2323.94%)Summary
- As of today (August 16, 2025), TAK quarterly working capital is $2.38 billion, with the most recent change of +$2.28 billion (+2323.94%) on June 1, 2025.
- Over the past year, TAK quarterly working capital has dropped by -$1.61 billion (-40.46%).
- TAK quarterly working capital is now -85.42% below its all-time high of $16.30 billion, reached on December 31, 2018.
Performance
TAK quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
TAK Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.0% | -40.5% |
| 3 y3 years | -97.3% | -15.2% |
| 5 y5 years | -96.4% | -42.3% |
TAK Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.3% | +115.5% | -49.1% | +477.1% |
| 5 y | 5-year | -98.8% | +115.5% | -72.1% | +477.1% |
| alltime | all time | -99.5% | +110.3% | -85.4% | +350.8% |
TAK Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.38B(+2323.9%) |
| Mar 2025 | $98.11M(-94.0%) | $98.05M(-97.7%) |
| Dec 2024 | - | $4.18B(-10.5%) |
| Sep 2024 | - | $4.67B(+17.0%) |
| Jun 2024 | - | $3.99B(+146.1%) |
| Mar 2024 | $1.62B(-357.0%) | $1.62B(+56.0%) |
| Dec 2023 | - | $1.04B(+64.5%) |
| Sep 2023 | - | $632.24M(-408.0%) |
| Jun 2023 | - | -$205.27M(-67.4%) |
| Mar 2023 | -$631.03M(-117.1%) | -$630.30M(-123.0%) |
| Dec 2022 | - | $2.74B(+11.8%) |
| Sep 2022 | - | $2.45B(-12.5%) |
| Jun 2022 | - | $2.80B(-23.7%) |
| Mar 2022 | $3.69B(-56.6%) | $3.67B(-36.8%) |
| Dec 2021 | - | $5.81B(+21.0%) |
| Sep 2021 | - | $4.80B(-31.0%) |
| Jun 2021 | - | $6.96B(-18.3%) |
| Mar 2021 | $8.50B(+212.8%) | $8.52B(+8.2%) |
| Dec 2020 | - | $7.87B(-5.0%) |
| Sep 2020 | - | $8.28B(+101.1%) |
| Jun 2020 | - | $4.12B(+51.7%) |
| Mar 2020 | $2.72B(-31.6%) | $2.72B(-24.7%) |
| Dec 2019 | - | $3.61B(-47.3%) |
| Sep 2019 | - | $6.85B(-20.1%) |
| Jun 2019 | - | $8.58B(+116.2%) |
| Mar 2019 | $3.98B(+23.9%) | $3.97B(-75.7%) |
| Dec 2018 | - | $16.30B(+602.5%) |
| Sep 2018 | - | $2.32B(-17.3%) |
| Jun 2018 | - | $2.81B(-12.6%) |
| Mar 2018 | $3.21B(-437.6%) | $3.21B(-6.6%) |
| Dec 2017 | - | $3.44B(+1.0%) |
| Sep 2017 | - | $3.41B(+15.2%) |
| Jun 2017 | - | $2.96B(-412.0%) |
| Mar 2017 | -$950.64M(-120.7%) | -$947.44M(-115.8%) |
| Dec 2016 | - | $6.00B(-10.0%) |
| Sep 2016 | - | $6.67B(+5.4%) |
| Jun 2016 | - | $6.33B(+37.7%) |
| Mar 2016 | $4.60B(+9.5%) | $4.60B(+2.8%) |
| Dec 2015 | - | $4.47B(+8.4%) |
| Sep 2015 | - | $4.12B(+9.8%) |
| Jun 2015 | - | $3.75B(-10.5%) |
| Mar 2015 | $4.20B | $4.19B(-42.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $7.25B(-7.2%) |
| Sep 2014 | - | $7.81B(+0.2%) |
| Jun 2014 | - | $7.80B(+1.6%) |
| Mar 2014 | $7.67B(+20.7%) | $7.67B(-33.1%) |
| Dec 2013 | - | $11.47B(-3.8%) |
| Sep 2013 | - | $11.92B(+39.9%) |
| Jun 2013 | - | $8.52B(+34.2%) |
| Mar 2013 | $6.36B(-0.8%) | $6.35B(-28.1%) |
| Dec 2012 | - | $8.82B(-9.1%) |
| Sep 2012 | - | $9.70B(+63.6%) |
| Jun 2012 | - | $5.93B(+61.4%) |
| Mar 2012 | $6.41B(-53.8%) | $3.68B(+33.5%) |
| Dec 2011 | - | $2.75B(-17.9%) |
| Sep 2011 | - | $3.35B(-76.6%) |
| Jun 2011 | - | $14.30B(+3.5%) |
| Mar 2011 | $13.87B(+13.3%) | $13.82B(+1.7%) |
| Dec 2010 | - | $13.59B(+1.2%) |
| Sep 2010 | - | $13.43B(+8.2%) |
| Jun 2010 | - | $12.41B(+1.4%) |
| Mar 2010 | $12.25B(+20.5%) | $12.23B(+6.3%) |
| Dec 2009 | - | $11.51B(-3.8%) |
| Sep 2009 | - | $11.97B(+18.1%) |
| Mar 2009 | $10.16B(-44.3%) | $10.14B(+2.4%) |
| Dec 2008 | - | $9.89B |
| Mar 2008 | $18.24B(+12.4%) | - |
| Mar 2007 | $16.22B(+1.6%) | - |
| Mar 2006 | $15.97B(+6.4%) | - |
| Mar 2005 | $15.00B(+14.8%) | - |
| Mar 2004 | $13.07B(+29.4%) | - |
| Mar 2003 | $10.10B(+37.5%) | - |
| Mar 2002 | $7.34B(+16.0%) | - |
| Mar 2001 | $6.33B(-8.6%) | - |
| Mar 2000 | $6.93B(+29.3%) | - |
| Mar 1999 | $5.36B(+28.8%) | - |
| Mar 1998 | $4.16B(-3.7%) | - |
| Mar 1997 | $4.32B(-5.8%) | - |
| Mar 1996 | $4.59B(-11.4%) | - |
| Mar 1995 | $5.18B(+26.0%) | - |
| Mar 1994 | $4.11B(+13.4%) | - |
| Mar 1993 | $3.63B(+27.0%) | - |
| Mar 1992 | $2.85B(+8.4%) | - |
| Mar 1991 | $2.63B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual working capital?
- What is the all time high annual working capital for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual working capital year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly working capital?
- What is the all time high quarterly working capital for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly working capital year-on-year change?
What is Takeda Pharmaceutical Company Limited annual working capital?
The current annual working capital of TAK is $98.11M
What is the all time high annual working capital for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual working capital is $18.24B
What is Takeda Pharmaceutical Company Limited annual working capital year-on-year change?
Over the past year, TAK annual working capital has changed by -$1.52B (-93.95%)
What is Takeda Pharmaceutical Company Limited quarterly working capital?
The current quarterly working capital of TAK is $2.38B
What is the all time high quarterly working capital for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly working capital is $16.30B
What is Takeda Pharmaceutical Company Limited quarterly working capital year-on-year change?
Over the past year, TAK quarterly working capital has changed by -$1.61B (-40.46%)